Drug

INOpulse®

Status:
Phase 2
Condition:
Sarcoidosis ILD
Intervention Type:
Inhaled Drug
Funder Type:
Industry

Drug Details

iNO stands for Inhaled Nitric Oxide. Nitric oxide is a colorless gas that is formed by the oxidation of nitrogen.

Study Purpose

A phase 2b, open label study to assess the safety and efficacy of increasing doses of pulsed, inhaled nitric oxide (iNO) in subjects with pulmonary fibrosis and sarcoidosis on long term oxygen therapy followed by a long term extension study

Find a Clinical Trial